Senores Pharmaceuticals provides an update regarding the acquisition of 8,454 equity shares of Havix Group Inc., as previously announced on March 11, 2025 and March 12, 2025.
As of April 22, 2025, the company has successfully completed the acquisition of 7,914 equity shares.
The acquisition of the remaining 540 equity shares is currently in process and is pending approvals from the Reserve Bank of India (RBI).
Consequently, the deadline for completing the acquisition of the remaining 540 equity shares has been extended by 60 days.